Prognostic Significance of Pretreatment Serum Cytokines in Classical Hodgkin Lymphoma

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical Cancer Research

• Publication date

  2013-10-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-13-1879PMID 24141626PMCID PMC3867576
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International Prognostic Score in advanced-stage Hodgkin's lymphoma: altered utility in the modern era.

  2012cited by this paper
• Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma.

  2011cited by this paper
• Prognostic impact of tumour‐infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma

  2009cited by this paper
• Functional coexpression of Interleukin (IL)‐7 and its receptor (IL‐7R) on Hodgkin and Reed‐Sternberg cells: Involvement of IL‐7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma

  2009cited by this paper
• Simple: A Sequential Immunoperoxidase Labeling and Erasing Method

  2009cited by this paper
• Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma

  2008cited by this paper
• Serum YKL-40 and Interleukin 6 Levels in Hodgkin Lymphoma

  2008cited by this paper
• Managing relapsed and refractory Hodgkin lymphoma

  2008cited by this paper
• The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma

  2007cited by this paper
• Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.

  2005cited by this paper
• IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma.

  2004cited by this paper
• Interactions Between Tissue Fibroblasts in Lymph Nodes and Hodgkin/Reed-Sternberg Cells

  2004cited by this paper
• The role of cytokines in classical Hodgkin lymphoma.

  2002cited by this paper
• Hodgkin's lymphoma: the pathologist's viewpoint.

  2002cited by this paper
• Interleukin 6 expression by Hodgkin/Reed–Sternberg cells is associated with the presence of ‘B’ symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease

  2002cited by this paper
• Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma.

  2002cited by this paper
• Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription.

  2000cited by this paper
• Soluble Cytokine Levels Correlate with the Activity and Clinical Stage of Hodgkin's Disease at Diagnosis

  2000cited by this paper
• A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

  1998cited by this paper
• Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease.

  1997cited by this paper
• Interleukin-6-associated laboratory parameters and immunohistochemistry in symptomatic stage A and B nodular sclerosing Hodgkin's disease in children.

  1997cited by this paper
• Immune response to human immunodeficiency virus (HIV) in healthcare workers occupationally exposed to HIV-contaminated blood.

  1997cited by this paper
• Serum cytokine levels correlate with clinical parameters in Hodgkin's disease.

  1995cited by this paper
• Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin's lymphoma.

  1991cited by this paper

• Soluble cytokines enhance risk prediction across all stages of classical Hodgkin lymphoma

  2026cites this paper
• Classical Hodgkin lymphoma associated with immune deficiency and dysregulation exhibits a prognosis similar to sporadic cases but with distinct predictive markers

  2026cites this paper
• Alles fließt - Liquid Biopsy in der Hämatologie

  2025cites this paper
• The relationship and clinical significance of serum cytokine expression level and skin pruritus in patients with Hodgkin lymphoma and angioimmunoblastic T-cell lymphoma.

  2024cites this paper
• Hodgkin lymphoma and liquid biopsy: a story to be told

  2024cites this paper
• Epstein–Barr virus-positive mucocutaneous ulcer arising in the oral region: A report of three cases and a review

  2024cites this paper
• The importance of serum calprotectin level in patients with lymphoma

  2023cites this paper
• Classical Hodgkin Lymphoma on the Background of Castleman Disease: A Case Report

  2023cites this paper
• sIL-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma

  2022cites this paper
• Phenotype, function and clinical significance of CD26+ and CD161+ Tregs in splenic marginal zone lymphoma.

  2022cites this paper
• Ferritin, sex, and the wildfire of inflammation in Hodgkin lymphoma

  2022cites this paper
• Hodgkin ' s Lymphoma : Current Views on the Problem

  2022cites this paper
• Assessment of endothelial progenitor cells, VEGF-A and SDF-1α in Hodgkin's lymphoma

  2021cites this paper
• Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma.

  2021cites this paper
• Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab

  2021cites this paper
• Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin Lymphoma

  2020cites this paper
• Prognostic Factors

  2020cites this paper
• A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin’s lymphoma

  2020cites this paper
• Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging

  2020cites this paper
• Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21

  2020cites this paper
• An update on disease biomarkers for Hodgkin lymphoma

  2020cites this paper
• Early serum TARC reduction predicts prognosis in advanced‐stage Hodgkin lymphoma patients treated with a PET‐adapted strategy

  2020cites this paper
• Parameters associated with sperm quality prior to chemotherapy in lymphoma patients

  2020cites this paper
• An Autopsy Case of an Elderly Patient with Classic Hodgkin Lymphoma Presenting with a Plethora of Clinical Symptoms and Signs

  2020cites this paper
• Impact of the soluble interleukin-2 receptor level in the relapsed or refractory phase on the clinical outcome of patients with diffuse large B-cell lymphoma

  2019cites this paper
• Circulating biomarkers in classical Hodgkin lymphoma

  2019influential citation
• Clinical impacts of inflammatory markers and clinical factors in patients with relapsed or refractory diffuse large B-cell lymphoma

  2019cites this paper
• Coexistence of Serum Monoclonal Gammopathy of Uncertain Significance and Hodgkin Lymphoma

  2019cites this paper
• Predictive value of soluble interlukin-2 receptor level at diagnosis on the outcome for patients with classical Hodgkin lymphoma treated with ABVD with or without radiotherapy

  2019cites this paper
• Prognostic Significance of IL-6 in Hodgkin Lymphoma

  2019cites this paper
• Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies

  2018cites this paper
• Precision Molecular Pathology of Hodgkin Lymphoma

  2018cites this paper
• An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era

  2018cites this paper
• SOHO State of the Art Updates and Next Questions: Hodgkin Lymphoma

  2018cites this paper
• IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma

  2018cites this paper
• Lymphomas diagnosed in an internal medicine department compared to lymphomas diagnosed in other departments

  2018cites this paper
• Treatment and Prognosis

  2018cites this paper
• Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.

  2017cites this paper
• Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma Diagnosis

  2017cites this paper
• Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations

  2017cites this paper
• Associations between elevated pre‐treatment serum cytokines and peripheral blood cellular markers of immunosuppression in patients with lymphoma

  2017cites this paper
• Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma.

  2017cites this paper
• Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphoma

  2017cites this paper
• Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer

  2017cites this paper
• Clinical significance of tryptophan catabolism in Hodgkin lymphoma

  2017cites this paper
• Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma

  2017cites this paper
• Granulocyte Macrophage Colony Stimulating Factor Level in Serum of Patient with Hodgkin Lymphoma Pre and Post-Chemotherapy

  2017cites this paper
• Blood biomarkers in adults with lymph node enlargement contribute to diagnostic significance of malignancy

  2017cites this paper
• Genetic, molecular and cellular determinants of the causal association between obesity and Hodgkin lymphoma

  2016cites this paper
• Neutrophil CD64 is upregulated in RA patients with lymphoma but not in other solid cancers

  2016cites this paper
• Prognostic factors in Hodgkin lymphoma.

  2016cites this paper
• High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma.

  2016cites this paper
• Novel agents in the treatment of Hodgkin lymphoma: Biological basis and clinical results.

  2016cites this paper
• Mechanisms underlying the association between obesity and Hodgkin lymphoma

  2016cites this paper
• Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma.

  2016cites this paper
• The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma

  2016cites this paper
• Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin‐1, sCD163 and sCD30 with TARC

  2016influential citation
• Decision-making in the management of adult classical Hodgkin’s lymphoma: determining the optimal treatment

  2015cites this paper
• Comprehensive serum cytokine analysis identi fi es IL-1RA and soluble IL-2R α as predictors of event-free survival in T-cell lymphoma

  2015cites this paper
• Targeting immune checkpoints in lymphoma

  2015cites this paper
• Prognostic Biomarkers for Hodgkin Lymphoma

  2015cites this paper
• TARC Predicts PET-Normalization and Event Free Survival in Relapsed/Refractory Hodgkin Lymphoma Patients Treated With Brentuximab Vedotin.

  2015cites this paper
• Imbalance of Pro- and Anti-Inflammatory Cytokines in Patients With cHL Persists Despite Treatment Compared With Control Subjects.

  2015cites this paper
• Lymphomagenesis in Hodgkin lymphoma.

  2015cites this paper
• Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma.

  2015cites this paper
• Elevated soluble IL‐2Rα, IL‐8, and MIP‐1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma

  2014cites this paper
• Prognostic Utility of Angiogenic Growth Factors; Basic FGF, VEGF and PDGF-bb in Patients with Lymphoma

  2014cites this paper
• Current status of prognostication in classical Hodgkin lymphoma

  2014cites this paper
• Prognostic Serum Cytokines in Classical Hodgkin Lymphoma—Letter

  2014cites this paper
• Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins

  2014cites this paper
• Difference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line

  2014cites this paper
• Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression

  2014cites this paper
• Personalized Medicine and Imaging Serum Interleukin-8 Re fl ects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins

  2014cites this paper